AFENTRA

Updated 45 days ago
Public Limited Company
  • Active - 01757721 (CH)
  • Age: 42 years
  • ID: 46433446/47
10 St. Bride Street, London, EC4A 4AD
• 06100 - Extraction of crude petroleum
• 82110 - Combined office administrative service activities
Afentra is an independent oil and gas company focused on acquiring and developing mature, producing assets in West Africa, with a diverse portfolio consisting of production, near-field development and exploration assets in Angola... Afentra plc is a London listed upstream oil and gas company, focused on acquiring production and near field development assets, with its core portfolio located in Angola. The Company is implementing a strategy that delivers enhanced value for stakeholders and long-term sustainable growth... Afentra plc is committed to operating in a safe, ethical and responsible manner and the Board recognises the importance of high standards of corporate governance. The Board has adopted the Quoted Companies Alliance Corporate Governance Code (QCA Code) which the Board considers appropriate for a Company of the size and stage in development of Afentra.
Also known as: AFENTRA PLC
Previous names: STERLING ENERGY PLC
Registration numbers: 01757721 (CH), 1757721 (W)
Primary location: London United Kingdom
  • 0
  • 0
Interest Score
5
HIT Score
0.69

UK Company Data

Company number
01757721
Account category
GROUP
Account ref. day
31
Account ref. month
12
Accounts next due date
2024-06-30
Accounts last made up date
2022-12-31
Returns next due date
2016-11-07
Returns last made up date
2015-10-10
Num. mort. charges
12
Num. mort. outstanding
2
Num. mort. part. satisfied
0
Num. mort. satisfied
10
Num. gen. partners
0
Num. lim. partners
0
Domain
afentraplc.com

Actual
www.afentraplc.com

IP
162.159.136.54, 162.159.137.54

Status
OK

Category
Company

People Also Viewed


  1. CAR SCOUTS BODYSHOP LIMITED
  2. SQUARE FASHIONS - squaretoiletries.com
  3. HAPPY FAMILY - happyfamilychinese.com
  4. AGRI FRONTIER GROWTH HUB - agrigrowthhub.com
  5. SMART PHARM - smart-pharm.com
0 comments Add a comment